Related Experiment Video
Updated: Jul 21, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.8K
COVID-19: Variants, Immunity, and Therapeutics for Non-Hospitalized Patients.
Cameron Y S Lee1,2, Jon B Suzuki2,3,4,5,6
1Private Practice in Oral, Maxillofacial and Reconstructive Surgery, Aiea, HI 96701, USA.
Biomedicines
|July 29, 2023
Summary
The global COVID-19 pandemic continues due to SARS-CoV-2 variants impacting vaccine effectiveness. This study reviews immune responses, vaccine efficacy, and available COVID-19 therapies.
Area of Science:
- Immunology
- Virology
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, remains a global health emergency.
- Over 600 million cases and 6 million deaths worldwide highlight the pandemic's severity.
- Emerging SARS-CoV-2 variants complicate vaccine efficacy and disease control efforts.
Purpose of the Study:
- To review the impact of SARS-CoV-2 variants on COVID-19 vaccine efficacy.
- To explore the human immune response, including B and T cell regulation and antibody function.
- To present current COVID-19 therapies for non-hospitalized patients.
Main Methods:
- Literature review and synthesis of existing research on SARS-CoV-2 variants.
- Analysis of immune response mechanisms related to COVID-19.
- Overview of therapeutic interventions and their limitations.
Main Results:
- SARS-CoV-2 variants can evade vaccine-induced immunity, leading to breakthrough infections.
- Vaccines and therapeutics have significantly reduced infections and deaths in the US.
- Understanding immune senescence and antibody effectiveness is crucial for managing long-term immunity.
- Current therapies like Paxlovid, Remdesivir, Molnupiravir, and convalescent plasma have limitations in accessibility.
Conclusions:
- Continued vigilance against SARS-CoV-2 variants is necessary.
- Further research into immune responses and therapeutic strategies is essential.
- Addressing challenges in therapy distribution is critical for patient care.
More Related Videos
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
54
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54
01:28Pneumonia IV: Management
359
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359
01:29Immune Response Against Viral Pathogens
826
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
826
01:27Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
01:51Vaccinations
44.7K
Overview
44.7K
01:23Immunological Memory
671
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
671